Broadspectrum Remedies Private Limited
About Broadspectrum Remedies Private Limited
Data last updated:
Broadspectrum Remedies Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 04 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2016PTC292175. Its GSTIN is 07AAGCB6681H1ZG (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aditya Kumar Chaubey (Managing Director) and Suresh Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 302 Aditya Tower Plot No.11 Lsc Savita Vihar Delhi – 110092, Delhi, India – 110092.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.33 Cr, a decline of 53% compared to the previous year. For the same year it recorded a net profit of ₹33,466 (net margin 0.1%) and EBITDA of ₹50,334 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 136% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Broadspectrum Remedies Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address302 Aditya Tower Plot No.11 Lsc Savita Vihar Delhi – 110092, Delhi, India – 110092
- IndustryChemicals, Manufacturing, Basic Chemical
To see the full contact details of Broadspectrum Remedies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Broadspectrum Remedies is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Broadspectrum Remedies Private Limited, buy the company report.
Financials of Broadspectrum Remedies Private Limited
FY 2025 filings availableBroadspectrum Remedies Private Limited reported revenue of ₹2.33 Cr (down 53% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 53% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 136%. EBITDA fell 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹50,334 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33,466 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Broadspectrum Remedies Private Limited, buy the company report.
Board of directors and KMP of Broadspectrum Remedies Private Limited
Broadspectrum Remedies Private Limited currently reports 2 directors and 1 key managerial person. 3 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kumar Sharma Also directs: GHV Life Sciences Private Limited | Additional Director | 28 Aug 2019 | 7 Years 2 Months | Current |
| Jyoti Pandey | Ceo | 21 Aug 2020 | 6 Years 2 Months | Current |
| Aditya Kumar Chaubey | Managing Director | 21 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
Broadspectrum Remedies Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vasani Electricals Private Limited | ₹2.33 Cr (FY 2024) | 5.0% | Rajkot, Gujarat, India | |||
| Ryder Trexim India Private Limited | ₹2.33 Cr (FY 2022) | 74.0% | Delhi, India | |||
| Aries Exim Company Private Limited | ₹2.33 Cr (FY 2025) | 51.0% | Kolkata, West Bengal, India | |||
| Appena Life Private Limited | ₹2.33 Cr (FY 2025) | 34.0% | Indore, Madhya Pradesh, India | |||
| Sunlips Sr India Private Limited | ₹2.33 Cr (FY 2021) | 122.0% | Kumhrarbhagwa, Kumhrar, Bihar, India | |||
| Broadspectrum Remedies Private Limitedthis company | ₹2.33 Cr (FY 2023) | ₹33,466 | 0.1% | -53.0% | Delhi, India | |
| Swapan Ghosh Jewellers Private Limited | ₹2.33 Cr (FY 2024) | -12.0% | Delhi, India | |||
| Nisarga Healthcare Private Limited | ₹2.33 Cr (FY 2025) | 21.0% | Satara, Maharashtra, India | |||
| Rachell Grand Ventures Private Limited | ₹2.33 Cr (FY 2019) | 10.0% | Erode, Tamil Nadu, India | |||
| V. S. R. Ornaments Private Limited | ₹2.33 Cr (FY 2025) | 136.0% | Rajkot, Gujarat, India | |||
| Gaurav Silk Mills Private Limited | ₹2.33 Cr (FY 2025) | 22.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Broadspectrum Remedies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Broadspectrum Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Broadspectrum Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Broadspectrum Remedies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCB6681H1ZG | Delhi | Active | 08 Mar 2019 |
To see the full GST registrations and return filing status of Broadspectrum Remedies Private Limited, buy the company report.
Recent activity
Broadspectrum Remedies Private Limited has 6 board changes on record since 2019: 3 appointments and 3 cessations. The latest: Aditya Kumar Chaubey was appointed as Managing Director on 21 Aug 2020.
Frequently asked questions
Broadspectrum Remedies is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 04 March 2016 (10+ years old) and is registered under CIN U24100DL2016PTC292175.
Broadspectrum Remedies has 3 current directors and KMP:
- Aditya Kumar Chaubey - Managing Director
- Suresh Kumar Sharma - Additional Director
- Jyoti Pandey - Ceo
The latest financial statements of Broadspectrum Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Broadspectrum Remedies is 07AAGCB6681H1ZG, registered in Delhi.
The CIN (Corporate Identification Number) of Broadspectrum Remedies is U24100DL2016PTC292175. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Broadspectrum Remedies was incorporated on 04 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Broadspectrum Remedies by revenue are Vasani Electricals Private Limited, Ryder Trexim India Private Limited, Aries Exim Company Private Limited, Appena Life Private Limited, Sunlips Sr India Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Aditya Kumar Chaubey was appointed as Managing Director on 21 Aug 2020. Jyoti Pandey was appointed as CEO on 21 Aug 2020. Neeta Rani ceased to be Director on 21 Aug 2020. Broadspectrum Remedies has 6 board changes on record in total.
The registered office of Broadspectrum Remedies is at 302 Aditya Tower Plot No.11 Lsc Savita Vihar Delhi – 110092, Delhi, India – 110092.
Broadspectrum Remedies operates in the chemicals industry, in the manufacturing segment.
The compliance status of Broadspectrum Remedies is compliant as of 26 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
